Minerva Biotechnologies

Minerva Biotechnologies employs nanoparticle technology to develop and identify potential drug candidates.

Founded in 1999 by Cynthia Bamdad, Minerva is based on Bamdad's work in using nanoparticles in fields such as drug discovery, proteomics, opto-electronics and nanoscale biosensors. The company shifted its strategy in 2001 to use its nanoparticle technology in-house to develop and identify potential drug candidates.